Biosynthetic Technologies acquires Innoleo

Indianapolis-based Biosynthetic Technologies, which makes synthetic compounds called estolides from organic fatty acids found in various bio-derived oils, has acquired Innoleo, a specialist in castor oil and derivatives located in Ohio.

The products of both companies have applications in multiple industries, including personal care.

“The unique structure of castor oil offers interesting properties, making it appropriate for various industrial applications,” said Mark Miller, CEO at Biosynthetic Technologies. In particular, he noted, it is high in ricinoleic acid, making it suitable in a wide variety of applications, including personal care.

Latest Issues

IFSCC Congress 2025

Palais des Festivals, Cannes
15th - 18th September 2025

SEPAWA Congress 2025

ECC Estrel Center, Berlin
15-17th October 2025